The present report included six BHD syndrome patients (five men) with a mean age of 66 ± 11 (SD) years who had a proven germline FLCN gene mutation and underwent TA for a renal tumor. This evidence concerns the gene FLCN and Birt-Hogg-Dubé syndrome.